Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Fiorucci

Showing results (21-30 of 269) with videos related to

Pageof 27
Sort By:
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 1, 2004
Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donorsRafael Perini, Stefano Fiorucci, John L Wallace
Handbook of Experimental Pharmacology|June 16, 2019
Obeticholic Acid: An Update of Its Pharmacological Activities in Liver DisordersStefano Fiorucci, Cristina Di Giorgio, Eleonora Distrutti
Nature Reviews. Drug Discovery|July 18, 2002
Potential cardioprotective actions of no-releasing aspirinJohn L Wallace, Louis J Ignarro, Stefano Fiorucci
Cardiovascular Drug Reviews|June 5, 2004
Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current statusStefano Fiorucci, Elisabetta Antonelli, Paola Tocchetti, et al.
World Journal of Gastroenterology|February 23, 2016
Gut microbiota role in irritable bowel syndrome: New therapeutic strategiesEleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, et al.
Future Medicinal Chemistry|May 11, 2012
Farnesoid X receptor: from medicinal chemistry to clinical applicationsStefano Fiorucci, Andrea Mencarelli, Elenora Distrutti, et al.
Expert Opinion on Therapeutic Patents|April 14, 2018
Farnesoid X receptor modulators 2014-present: a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.
Expert Opinion on Therapeutic Patents|July 18, 2015
Farnesoid X receptor modulators (2011 - 2014): a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.
Biochimica Et Biophysica Acta|April 28, 2009
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophagesBarbara Renga, Marco Migliorati, Andrea Mencarelli, et al.
Journal of Lipid Research|September 29, 2009
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese ratsSabrina Cipriani, Andrea Mencarelli, Giuseppe Palladino, et al.
Pageof 27

Showing results (21-30 of 269) with videos related to

Sort By:
Pageof 27
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 1, 2004
Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donorsRafael Perini, Stefano Fiorucci, John L Wallace
Handbook of Experimental Pharmacology|June 16, 2019
Obeticholic Acid: An Update of Its Pharmacological Activities in Liver DisordersStefano Fiorucci, Cristina Di Giorgio, Eleonora Distrutti
Nature Reviews. Drug Discovery|July 18, 2002
Potential cardioprotective actions of no-releasing aspirinJohn L Wallace, Louis J Ignarro, Stefano Fiorucci
Cardiovascular Drug Reviews|June 5, 2004
Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current statusStefano Fiorucci, Elisabetta Antonelli, Paola Tocchetti, et al.
World Journal of Gastroenterology|February 23, 2016
Gut microbiota role in irritable bowel syndrome: New therapeutic strategiesEleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, et al.
Future Medicinal Chemistry|May 11, 2012
Farnesoid X receptor: from medicinal chemistry to clinical applicationsStefano Fiorucci, Andrea Mencarelli, Elenora Distrutti, et al.
Expert Opinion on Therapeutic Patents|April 14, 2018
Farnesoid X receptor modulators 2014-present: a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.
Expert Opinion on Therapeutic Patents|July 18, 2015
Farnesoid X receptor modulators (2011 - 2014): a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.
Biochimica Et Biophysica Acta|April 28, 2009
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophagesBarbara Renga, Marco Migliorati, Andrea Mencarelli, et al.
Journal of Lipid Research|September 29, 2009
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese ratsSabrina Cipriani, Andrea Mencarelli, Giuseppe Palladino, et al.
Pageof 27